AI assistant
Sending…
SynAct Pharma — Major Shareholding Notification 2023
Dec 27, 2023
3114_iss_2023-12-27_25ee35c4-5fa4-4119-b14a-53130e7447d9.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer SynAct Pharma AB
Holder
Nordnet AB (publ)
Instrument
| Instrument | Aktie SE0008241491 |
|---|---|
| Before the transaction | |
| Shares | 1,784,905 |
| Voting rights | 1,784,905 |
| Transaction | |
| Reason for major shareholding notification Sell | |
| Date | 22/12/2023 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 1,775,184 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 1,775,184 |
| Percentage | |
| Directly held shares | 4.99054 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 4.99054 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 4.99054 % | 1,775,184 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | 0.00281 % | 1,000 |
| Total | 4.99335 % | 1,776,184 |
Chain of controlling companies
| Voting rights % Voting rights Company | ||
|---|---|---|
| 1,728,771 4.86006 | Nordnet Pensionsförsäkring AB | |
| 47,413 | 0.13329 | Nordnet Livsforsikring AS |
| Group total holdings |
||
| Voting rights | 1,776,184 | |
| Percentage of voting rights 4.99335 | ||
Published
| 27/12/2023 11:36 | ||
|---|---|---|
| Contact | ||
| Name | Rasmus Reivilä |
| Phone | 0704056744 | Email [email protected] |
|---|---|---|
| ------- | ------------ | --------------------------------- |

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from SynAct Pharma
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Board/Management Information
2026
Apr 23
Governance Information
2026
Apr 23
Annual Report
2026
Apr 15
Major Shareholding Notification
2026
Apr 7
Share Issue/Capital Change
2026
Mar 31
Share Issue/Capital Change
2026
Mar 31
Major Shareholding Notification
2026
Mar 27
Capital/Financing Update
2026
Mar 2